Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis.
about
Melatonin for the treatment of dementiaDementia.Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis.Alzheimer's therapies.Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans.A review of the effectiveness of antidepressant medications for depressed nursing home residents.White matter hyperintensities and the course of depressive symptoms in elderly people with mild dementiaMeasuring symptoms of depression: comparing the Cornell Scale for Depression in Dementia and the Patient Health Questionnaire-9-Observation VersionTranslating geriatric psychiatry research into practice: coping with uncertaintyManagement of patients with Alzheimer's disease: pharmacological treatment and quality of lifePrevention and clinical management of hip fractures in patients with dementia.Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease.Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease.Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?Insight in Alzheimer's disease and its relation to psychiatric and behavioral disturbances.Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Associations between depressive symptoms and memory deficits vary as a function of insulin-like growth factor (IGF-1) levels in healthy older adults.Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia.The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.What is the therapeutic value of antidepressants in dementia? A narrative review.How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?Treatments for Depression in Older Persons with Dementia.Effect of Bright Light Exposure on Depression and Agitation in Older Adults with Dementia.Emerging treatments for the behavioral and psychological symptoms of dementia.CARES(®) Dementia Care for Families™: Effects of Online, Psychoeducational Training on Knowledge of Person-Centered Care and Satisfaction.[Developmental process of DGPPN quality indicators].Depression in Alzheimer's disease: specificity of depressive symptoms using three different clinical criteria.Relation between neuritic plaques and depressive state in Alzheimer's disease.
P2860
Q24244870-74A9BF29-19B8-4855-9FB4-56BA55119C08Q30404451-B71DD6F9-E810-48BB-8BD3-BA2B7A1F6A3CQ33539531-FA00E17E-C305-4C5F-9557-0E54CF44EC88Q33751924-82BB8EA9-E866-4CB1-A3D2-642110C04DFDQ33787893-E0D4A4B0-3985-45B1-95B4-2B66488F11FEQ33894697-DA91904E-2135-404D-A16A-5C1316378DAAQ34079552-1E9263FA-7396-41D1-8AC5-A593ADA00247Q35923199-FE29BC60-20B1-4C8F-B6F5-7D26DD771ADAQ35945393-14896EBF-2541-4CF2-962B-743D39DDDE43Q35996012-8B795AC6-512C-4890-A1B5-E956887A0456Q36450570-A6550CCE-B8EB-49D6-A7EB-0D9E34B302C7Q36515587-689DD5A1-DF1A-4272-8891-D42A5D9A9AA9Q36683969-96ACD3E3-A799-476E-8427-17D7FA7AE742Q36978027-EE55604E-BDBB-483F-B489-5948FC5CC688Q37004363-6FC54F90-130B-4E77-AE1A-D65F5D939EB0Q37118083-89399EF7-A150-438E-8BF2-C5B20CA699A5Q37228449-55115BCA-FADC-4473-AA2E-381AFEC880B2Q37693772-0C35E461-75FF-47B6-BAB4-7766C92F783DQ37718687-00DDF761-DC55-4C1B-A8A8-D0F1CDE1B9BFQ37986567-72E54CE0-3F0C-4796-AA9B-6CCEC980A058Q38737187-A1EAD318-F604-42F7-A387-507E32CEDD7FQ38813696-F5109FCE-5079-4199-A6B6-9D0FBB4FAEE7Q38946127-E0E82DE5-D406-4E5E-A997-920F9DE1A355Q38962789-60AFE3D1-8B0B-4384-8486-259657E2FCF0Q39027923-9A3A89F5-89B0-4C8A-9DD6-0246C984176DQ42848862-0C3C72C1-C28A-41AA-BA13-C1F6DA4BFB34Q45035349-859115FB-D017-486A-9196-FF0BCC3701B0Q47621726-F311D2EF-DE98-47A3-9AF5-8BA533E479EFQ49598308-D5594197-1AFE-48AF-8D7B-42D527A110B4Q50754002-DBE54A3C-CE8D-47FC-AE25-5C28690759B7Q51425595-11634BD2-E504-4084-91A2-2AAE633704C9Q53358488-38BFA4EA-8071-4A14-AEFE-ABABD81997CD
P2860
Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Efficacy and safety of antidep ...... mer's disease: a metaanalysis.
@ast
Efficacy and safety of antidep ...... mer's disease: a metaanalysis.
@en
Efficacy and safety of antidep ...... mer's disease: a metaanalysis.
@nl
type
label
Efficacy and safety of antidep ...... mer's disease: a metaanalysis.
@ast
Efficacy and safety of antidep ...... mer's disease: a metaanalysis.
@en
Efficacy and safety of antidep ...... mer's disease: a metaanalysis.
@nl
prefLabel
Efficacy and safety of antidep ...... mer's disease: a metaanalysis.
@ast
Efficacy and safety of antidep ...... mer's disease: a metaanalysis.
@en
Efficacy and safety of antidep ...... mer's disease: a metaanalysis.
@nl
P2093
P2860
P1476
Efficacy and safety of antidep ...... mer's disease: a metaanalysis.
@en
P2093
Mark J Rapoport
Nathan Herrmann
Sarah Thompson
P2860
P304
P356
10.1177/070674370705200407
P407
P577
2007-04-01T00:00:00Z